I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 37 studies | 43% ± 23% | |
| fibroblast | 35 studies | 44% ± 26% | |
| macrophage | 24 studies | 39% ± 23% | |
| astrocyte | 19 studies | 42% ± 19% | |
| plasma cell | 17 studies | 41% ± 23% | |
| pericyte | 17 studies | 46% ± 24% | |
| smooth muscle cell | 16 studies | 42% ± 21% | |
| microglial cell | 15 studies | 44% ± 17% | |
| oligodendrocyte precursor cell | 12 studies | 39% ± 17% | |
| epithelial cell | 11 studies | 44% ± 24% | |
| myeloid cell | 11 studies | 40% ± 17% | |
| adipocyte | 11 studies | 76% ± 16% | |
| monocyte | 10 studies | 48% ± 25% | |
| natural killer cell | 10 studies | 29% ± 16% | |
| classical monocyte | 10 studies | 28% ± 8% | |
| endothelial cell of artery | 10 studies | 34% ± 18% | |
| mesothelial cell | 10 studies | 48% ± 19% | |
| endothelial cell of lymphatic vessel | 9 studies | 51% ± 21% | |
| type I pneumocyte | 9 studies | 51% ± 23% | |
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 25% ± 15% | |
| basal cell | 9 studies | 43% ± 25% | |
| ciliated cell | 9 studies | 37% ± 19% | |
| alveolar macrophage | 8 studies | 45% ± 31% | |
| vein endothelial cell | 8 studies | 44% ± 26% | |
| neutrophil | 7 studies | 33% ± 20% | |
| myofibroblast cell | 7 studies | 35% ± 23% | |
| club cell | 7 studies | 47% ± 22% | |
| capillary endothelial cell | 7 studies | 26% ± 11% | |
| mast cell | 7 studies | 29% ± 14% | |
| endothelial cell of vascular tree | 7 studies | 36% ± 22% | |
| connective tissue cell | 7 studies | 37% ± 21% | |
| cardiac muscle cell | 6 studies | 60% ± 24% | |
| dendritic cell | 6 studies | 31% ± 9% | |
| type II pneumocyte | 6 studies | 58% ± 15% | |
| glutamatergic neuron | 6 studies | 37% ± 19% | |
| hepatocyte | 5 studies | 69% ± 18% | |
| GABAergic neuron | 5 studies | 36% ± 12% | |
| podocyte | 5 studies | 51% ± 29% | |
| IgG plasma cell | 5 studies | 27% ± 12% | |
| respiratory goblet cell | 5 studies | 48% ± 23% | |
| T cell | 5 studies | 31% ± 16% | |
| non-classical monocyte | 4 studies | 22% ± 9% | |
| cholangiocyte | 4 studies | 67% ± 17% | |
| interneuron | 4 studies | 33% ± 18% | |
| lymphocyte | 4 studies | 38% ± 15% | |
| Mueller cell | 4 studies | 34% ± 10% | |
| retinal rod cell | 4 studies | 22% ± 4% | |
| abnormal cell | 4 studies | 41% ± 28% | |
| muscle cell | 4 studies | 45% ± 19% | |
| goblet cell | 4 studies | 39% ± 33% | |
| neuron | 4 studies | 43% ± 25% | |
| plasmablast | 4 studies | 38% ± 22% | |
| IgA plasma cell | 4 studies | 33% ± 19% | |
| squamous epithelial cell | 3 studies | 34% ± 21% | |
| pancreatic A cell | 3 studies | 28% ± 9% | |
| type B pancreatic cell | 3 studies | 34% ± 16% | |
| endothelial cell of sinusoid | 3 studies | 49% ± 8% | |
| hepatic stellate cell | 3 studies | 72% ± 16% | |
| granule cell | 3 studies | 29% ± 14% | |
| progenitor cell | 3 studies | 28% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 30% ± 11% | |
| endocardial cell | 3 studies | 47% ± 15% | |
| secretory cell | 3 studies | 28% ± 8% | |
| retinal pigment epithelial cell | 3 studies | 50% ± 17% | |
| ependymal cell | 3 studies | 51% ± 12% | |
| adventitial cell | 3 studies | 45% ± 22% | |
| chondrocyte | 3 studies | 54% ± 28% | |
| oligodendrocyte | 3 studies | 32% ± 14% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 60% ± 25% | |
| kidney loop of Henle epithelial cell | 3 studies | 43% ± 18% | |
| mural cell | 3 studies | 50% ± 4% | |
| mucus secreting cell | 3 studies | 58% ± 12% | |
| myoepithelial cell | 3 studies | 52% ± 26% |
